Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 6Gynecologic 3Genitourinary 3Breast 3Other hematologic neoplasm 2Gastrointestinal 2CNS 2Tumor-Agnostic 1Endocrine 1Classical hematology 1

Conditions

Cancer-related Venous Thromboembolism 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Whole-Body Irradiation 5Mycophenolic Acid 4Tacrolimus 3Rituximab 3Peripheral Blood Stem Cell Transplantation 3Cyclosporine 3Busulfan 3fludarabine 2apixaban 2Methotrexate 2Melphalan 2Lenalidomide 2Etoposide 2CT-P10 2Biopsy 2Azacitidine 2venetoclax 1thymoglobulin 1merphos 1ivosidenib 1ibrutinib 1edoxaban 1Vorinostat 1Thiotepa 1TAK-243 1Surveys and Questionnaires 1Specimen Handling 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Surveys and Questionnaires × Classical hematology × 30 days × Clear all
NCT03407469 2026-05-20

Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

M.D. Anderson Cancer Center

Recruiting
260 enrolled
Classical hematology

Cancer-related Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡